Amlodipine/Losartan/Rosuvastatin/Ezetimibe
- Generic Name
- Amlodipine/Losartan/Rosuvastatin/Ezetimibe
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 61
- Registration Number
- NCT04322266
- Locations
- 🇰🇷
Korea University Hospital (Anam), Seoul, Korea, Republic of
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Phase 3
Completed
- Conditions
- HypertensionDyslipidemias
- Interventions
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 145
- Registration Number
- NCT04074551
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Seoul-si, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath